RBM12 Maintains Glioma Stem Cells by Activating Amino Acid‐Dependent mTORC1 Signaling via SLC7A5 mRNA Stabilization
Advanced Science · 2026-09 · 13 (52)
DOI: 10.1002/advs.76239 ↗At a glance
Journal article in Advanced Science, published online on 2026-06-22. Written by Hong Lei and 18 co-authors. Institution: College of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China. Major MEDLINE topics: Mechanistic Target of Rapamycin Complex 1, RNA-Binding Proteins, Neoplastic Stem Cells, Large Neutral Amino Acid-Transporter 1. Cited 1 times so far (Crossref); 61 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, High-Level Talent Research Startup Fund of Huazhong Agricultural University.
Abstract (original language)
Reprogramming of amino acid metabolism is crucial for the rapid proliferation of cancer cells, including cancer stem cells. However, the molecular mechanisms underlying this reprogramming in glioma stem cells (GSCs) remain poorly understood. Here, we report that the RNA‐binding protein RBM12 increases the intracellular levels of large neutral amino acids, thereby activating the mTORC1 pathway and promoting GSC proliferation, self‐renewal, and glioblastoma (GBM) growth. Mechanistically, RBM12 stabilizes the mRNA of the amino acid transporter SLC7A5 , thereby increasing intracellular levels of large neutral amino acids, which subsequently activates the mTORC1 pathway. Further studies reveal that RBM12 enhances SLC7A5 mRNA stability by recruiting ALKBH5 to remove m 6 A modifications on SLC7A5 mRNA. Importantly, pharmacological inhibition of the RBM12‐SLC7A5 axis using the SLC7A5 inhibitor JPH203 effectively suppresses GBM growth. These findings elucidate a novel role for RBM12‐SLC7A5 signaling in the malignant growth of GBM and highlight the therapeutic potential of targeting this axis for GBM treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
- National Health Commission Key Laboratory of Antibody Techniques, Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu, China.
- Hubei Provincial Clinical Research Center of Central Nervous System Repair and Functional Reconstruction, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- China Exposomics Institute, Shanghai, China.
ORCID profiles: Zhen Xue, Jianghong Man, Wenchao Zhou, Zhiqiang Dong
Funding
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- High-Level Talent Research Startup Fund of Huazhong Agricultural University
- Natural Science Foundation of Hubei Province
Cite
APA
Lei, H., Luo, W., Zhou, S., Wan, L., Ling, P., Huang, Z., Qian, Z., Lu, C., Guo, M., Xue, Z., Qin, J., Zhao, N., Man, J., Zhou, W., Dong, Z., Xu, S., Zhou, Z., Wang, X., & Tao, W. (2026). RBM12 Maintains Glioma Stem Cells by Activating Amino Acid‐Dependent mTORC1 Signaling via SLC7A5 mRNA Stabilization. Advanced Science, 13(52). https://doi.org/10.1002/advs.76239
Vancouver
Lei H, Luo W, Zhou S, Wan L, Ling P, Huang Z, et al. RBM12 Maintains Glioma Stem Cells by Activating Amino Acid‐Dependent mTORC1 Signaling via SLC7A5 mRNA Stabilization. Advanced Science. 2026;13(52). doi:10.1002/advs.76239
BibTeX
@article{Lei2026,
author = {Lei, Hong and Luo, Wenlong and Zhou, Shu and Wan, Lihao and Ling, Peng and Huang, Zhihua and Qian, Zhihua and Lu, Chenfei and Guo, Mengyue and Xue, Zhen and Qin, Jun and Zhao, Ningwei and Man, Jianghong and Zhou, Wenchao and Dong, Zhiqiang and Xu, Shutong and Zhou, Zhipeng and Wang, Xiuxing and Tao, Weiwei},
title = {RBM12 Maintains Glioma Stem Cells by Activating Amino Acid‐Dependent mTORC1 Signaling via SLC7A5 mRNA Stabilization},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {52},
doi = {10.1002/advs.76239}
}
EUVIMED